Cutaneous Events Associated with Immunotherapy of Melanoma: A Review

Immunotherapy with checkpoint inhibitors significantly improves the outcome for stage III and IV melanoma. Cutaneous adverse events during treatment are often reported. We herein aim to review the principal pigmentation changes induced by immune check-point inhibitors: the appearance of vitiligo, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Burzi, Lorenza, Alessandrini, Aurora Maria, Quaglino, Pietro, Piraccini, Bianca Maria, Dika, Emi, Ribero, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308045/
https://www.ncbi.nlm.nih.gov/pubmed/34300213
http://dx.doi.org/10.3390/jcm10143047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308045/
https://www.ncbi.nlm.nih.gov/pubmed/34300213
http://dx.doi.org/10.3390/jcm10143047

Ejemplares similares